Full text is available at the source.
Abstract
Substance-assisted psychotherapy with serotonergic psychoactive agents shows potential for treating conditions like PTSD and depression.
- Evidence suggests that LSD and psilocybin may be effective in treating alcohol and tobacco addiction.
- Psilocybin is associated with positive outcomes in anxiety and depression among patients with life-threatening illnesses.
- Studies indicate that psilocybin could benefit individuals with obsessive-compulsive disorder (OCD) and treatment-resistant major depression.
- MDMA shows promise in addressing posttraumatic stress disorder (PTSD).
- Overall, findings indicate efficacy and relatively good tolerability for these substances in therapeutic contexts.
- Further research is necessary to establish the suitability of these substances for treatment-resistant psychiatric disorders.
Simplified